FMR LLC 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 2,785,284 5.080% | 10,912 (+0.39%) | Filing |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 2,774,372 6.243% | -533,238 (-16.12%) | Filing |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 3,307,610 7.463% | -841,036 (-20.27%) | Filing |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 4,148,646 15.000% | 1,003,444 (+31.90%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 3,145,202 14.999% | 73,306 (+2.39%) | Filing |
| 2021-06-10 11:37 am Purchase | 2021-06-09 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 3,071,896 15.229% | 3,071,896 (New Position) | Filing |